MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Let’s Talk Medtech

Dexcom’s CEO Joins Let’s Talk Medtech for a Candid Discussion on Firm’s Future

Image courtesy of Dexcom Let's Talk Medtech guest Dexcom CEO
No topic is off-limits, as Dexcom CEO Kevin Sayer gives an update on the G7 CGM; discusses the competitive landscape; and talks about the collaboration with Nick Jonas.


Dexcom CEO, Kevin Sayer - Courtesy of Dexcom IMG_Jun292021at22713PM.png

The role of Continuous Glucose Monitoring is growing in diabetes management – and Dexcom aims to be the frontrunner in the space. The San Diego, CA-based company has its G7 CGM on the horizon; solid studies that were presented at the American Diabetes Association 81st Scientific Sessions; diabetes driving telemedicine; and even that Super Bowl Commercial collaboration with Nick Jonas.

Dexcom’s CEO Kevin Sayer checks in for this episode of Let’s Talk Medtech and discusses the company’s recent activities and paints a picture of what the future of CGM will look like.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.